selumetinib

Italy

Drugs containing this active substance

  • KOSELUGO

    It is used to treat adults and children (from 3 years of age for capsules, from 1 year of age for granules) suffering from plexiform neurofibromas that cannot be completely removed by surgery. These tumors are caused by neurofibromatosis type 1 (NF1).

    Form: capsules, hard gelatin

    Active substance Dosage
    selumetinib -

    ATC: L01EE04

    Manufacturer: ASTRAZENECA AB